Study: Remdesivir Significantly Reduces Risk of Hospitalization in High-Risk Patients with COVID19

According to a Gilead press release, more than half of patients hospitalized with COVID19 in the United States are treated with remdesivir because it directly …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 20,000 other readers who rate their headlines through us